What is element eight?
Element Eight operates at the intersection of biotechnology and luxury skincare, focusing on the critical role of oxygen in dermal health. The company addresses the physiological decline of skin oxygen levels—which can drop by up to 50% by age 50—through advanced delivery systems designed to stimulate collagen synthesis and structural protein repair. By targeting the root causes of hyperpigmentation, dehydration, and wrinkle formation, the brand differentiates itself from traditional cosmetic offerings. Its market position is defined by a commitment to clinical validation, utilizing independent laboratory testing to demonstrate efficacy in skin repair and environmental stress recovery. This evidence-based approach provides a robust foundation for its expansion into the global beauty and wellness industry.
How much funding has element eight raised?
element eight has raised a total of $6M across 1 funding round:
Other Financing Round
$6M
Other Financing Round (2023): $6M, investors not publicly disclosed
Key Investors in element eight
Undisclosed Investor
An undisclosed institutional partner providing strategic capital to support the scaling of high-growth consumer health and beauty brands.
Undisclosed Investor
A private investment firm specializing in early-to-growth stage companies within the life sciences and wellness sectors.
Undisclosed Investor
A diversified holding entity focused on long-term value creation in the premium retail and dermatological technology markets.
What's next for element eight?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the company's distribution channels and enhancing its research and development pipeline. As Element Eight scales, the focus will shift toward optimizing supply chain logistics and increasing brand visibility through targeted clinical marketing campaigns. The current funding context suggests a move toward long-term sustainability and market dominance, with potential for further product diversification. By maintaining its rigorous focus on oxygen-based skin rejuvenation, the company is poised to capture a larger share of the premium skincare market, potentially attracting further institutional interest as it continues to demonstrate measurable clinical outcomes and strong consumer retention metrics.
See full element eight company page
